Value of PET/CT in the management of liver metastases, part 1

Ari Sacks, Patrick J. Peller, Devaki S. Surasi, Luke Chatburn, Gustavo Mercier, Rathan M. Subramaniam

Research output: Contribution to journalReview article

54 Scopus citations

Abstract

OBJECTIVE. Metastasis is the most common (95%) of liver lesions. Early diagnosis and staging are the keys to treatment planning and prognosis. There is a consistent benefit to the use of PET/CT for detecting hepatic, local, and distant metastases from a variety of primary malignancies, which can contribute to staging and ultimately helps to establish the best course of treatment and to determine prognosis. CONCLUSION. For colorectal cancer, FDG PET and FDG PET/CT are particularly effective for identification of additional hepatic and extrahepatic metastases, frequently upstaging the tumor stage and affecting management. In addition, PET/CT is very useful in local ablative and systemic therapy assessment and surveillance for liver metastases.

Original languageEnglish (US)
Pages (from-to)W256-W259
JournalAmerican Journal of Roentgenology
Volume197
Issue number2
DOIs
StatePublished - Aug 1 2011

Keywords

  • F-FDG
  • Hepatobiliary tumors
  • PET/CT
  • Staging
  • Therapy assessment

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Value of PET/CT in the management of liver metastases, part 1'. Together they form a unique fingerprint.

  • Cite this

    Sacks, A., Peller, P. J., Surasi, D. S., Chatburn, L., Mercier, G., & Subramaniam, R. M. (2011). Value of PET/CT in the management of liver metastases, part 1. American Journal of Roentgenology, 197(2), W256-W259. https://doi.org/10.2214/AJR.10.6331